Julia G. Johnson
University of Minnesota
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Julia G. Johnson.
Immunological Reviews | 1997
Kathryn A. Pape; Elizabeth R. Kearney; Alexander Khoruts; Anna Mondino; Rebecca Merica; Zong Ming Chen; Elizabeth Ingulli; Jennifer A. White; Julia G. Johnson; Marc K. Jenkins
Summary: Adoptive transfer of TCR‐transgenic T cells uniformly expressing an identifiable TCR of known peptide/MHC specificity can be used to monitor the in vivo behavior of antigen‐specific T cells. We have used this system to show that naive T cells are initially activated within the T‐cell zones of secondary lymphoid tissue to prohferate in a B7‐dependent manner. If adjuvants or inflammatory cytokines are present during this period, enhanced numbers of T cells accumulate, migrate into B‐cell‐rich follicles, and acquire the capacity to produce IFN‐7 and help B cells produce IgG2a. If inflammation is absent, most of the initially activated antigen‐specific T cells disappear without entering the follicles and the survivors are poor producers of IL‐2 and IFN‐γ Our results indicate that inflammatory mediators play a key role in regulating the anatomic location, clonal expansion, survival and lymphokine production potential of antigen‐stimulated T cells in vivo.
Immunologic Research | 1993
Julia G. Johnson; Marc K. Jenkins
Various populations of accessory cells differ in their abilities to function as effective antigen-presenting cells (APC) and stimulate CD4+ T cells to produce interleukin-2. Three important factors directly related to APC potency are the expression of class II major histocompatibility complex molecules and the ability to present peptide antigens to the T cell antigen receptor, the expression of costimulatory ligands which deliver important activation signals independent of T cell receptor occupancy and the expression of adhesion molecules which promote conjugate formation so that these activation signals can be effectively delivered to the T cells. The relative importance of these accessory cell functions in T cell activation will be discussed, with an emphasis on costimulation and the CD28/B7 receptor/ligand pair. The consequence of inadequate costimulation by an otherwise effective APC in inducting T cell anergy will also be discussed. *** DIRECT SUPPORT *** A02GS021 00006
Advances in Experimental Medicine and Biology | 1993
Marc K. Jenkins; Dimuthu R. DeSilva; Julia G. Johnson; Steven D. Norton
The antigen-specific activation of CD4+ T lymphocytes is absolutely dependent on ligands expressed on the surface of specialized hematopoietic cells1 known as antigenpresenting cells (APC). Recent results from many laboratories suggest that these ligands include: major histocompatibility complex (MHC) -encoded class II molecules that are important for presenting antigenic peptides to the T cell antigen receptor (TCR); adhesion molecules that facilitate the formation of T cell/APC conjugates; and molecules that transduce nonspecific costimulatory signals upon binding their complementary T cell receptors1-3. The efficiency of various APC types in their capacity to stimulate T cells can therefore be influenced by qualitative and/or quantitative differences in the expression or function of any of these molecules. Here we describe our analysis of the contribution of antigen-presentation, adhesion, and costimulation to the functional APC potency of dendritic cells and B cells.
Science | 1998
Paul Garside; Elizabeth Ingulli; Rebecca Merica; Julia G. Johnson; Randolph J. Noelle; Marc K. Jenkins
Current Opinion in Immunology | 1993
Marc K. Jenkins; Julia G. Johnson
Journal of Immunology | 1999
Angela L. Zarling; Julia G. Johnson; Robert W. Hoffman; David R. Lee
European Journal of Immunology | 1991
Ronald Jemmerson; Julia G. Johnson; Edwin Burrell; P. Sean Taylor; Marc K. Jenkins
Journal of Immunology | 1994
Julia G. Johnson; Marc K. Jenkins
Life Sciences | 1994
Julia G. Johnson; Marc K. Jenkins
Journal of Investigative Dermatology | 1992
Julia G. Johnson; Marc K. Jenkins